Improvement of Bone Turnover Markers and Bone Mineral Density following treatment of Primary Aldosteronism.
CONCLUSIONS: Our findings support that bone loss and potential fracture risk among PA patients are likely a result of aldosterone-mediated secondary hyperparathyroidism. Patients with early PA may already exhibit increased bone turnover despite no significant changes in BMD.
PMID: 28001017 [PubMed - as supplied by publisher]
Source: Minerva Endocrinologica - Category: Endocrinology Tags: Minerva Endocrinol Source Type: research
More News: Calcium | Endocrinology | Hormones | Hyperparathyroidism | Hypertension | Orthopaedics | Study | Vitamins